Tal Zvi Zaks, Chief Medical Officer at Moderna, Inc. (MRNA), sold 5,640 shares at $185.82 ($1.0M) on 2021-02-08, disclosed to the SEC on 2021-02-09.
Open-market sale of $1.0M MRNA by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $178.20 | 100 | $18K | 1.7% |
| 2 | $179.43 | 300 | $54K | 5.2% |
| 3 | $180.74 | 100 | $18K | 1.7% |
| 4 | $182.92 | 400 | $73K | 7.0% |
| 5 | $185.03 | 1,404 | $260K | 24.9% |
| 6 | $185.03 | 1,404 |
| $260K |
| 24.9% |
| 7 | $185.82 | 566 | $105K | 10.1% |
| 8 | $185.82 | 566 | $105K | 10.1% |
| 9 | $186.84 | 800 | $149K | 14.3% |
| Total | $184.80 avg | 5,640 | $1.0M | 100% |
| Filing → |
| MRNA | SELL | 2021-06-25 | $1.1M | — | Filing → |
| MRNA | SELL | 2021-06-21 | $1.0M | — | Filing → |
| MRNA | SELL | 2021-06-11 | $1.1M | — | Filing → |